compare_entities
Exposed by 1313 servers, with 2 different definitions behind the one name.
The same name does not mean the same tool here.
1313 servers expose compare_entities and we have recorded 2 distinct definitions of it. Compare the parameters below before assuming one is a drop-in for another.
BPS — Badan Pusat Statistik (Statistics Indonesia) WebAPI MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
BPstat — Banco de Portugal statistics API (Portuguese central bank). Keyless.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
brapi.dev MCP — Brazilian stock + crypto + ETF quotes.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Brave Search MCP — independent web index (no Google/Bing dependency)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Brawl Stars player, club, brawlers, events, rankings. Supercell dev key.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Brazil PNCP MCP — Brazilian government procurement (keyless).
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Breweries MCP — Open Brewery DB API (free, no auth)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Bright Data MCP — Bright Data Web Unlocker + SERP API (brightdata.com)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Brønnøysund Register Centre (BRREG) MCP — Norway's official business register.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
U.S. Bureau of Transportation Statistics (BTS) — data.bts.gov open-data portal (Socrata platform).
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Deutsche Bundesbank (Germany's central bank) statistics MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Bundestag DIP MCP
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Bundlephobia MCP — npm bundle-size analysis
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Bungie.net Destiny 2 + clan API: manifest, profile, characters, stats.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Business Feeds MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
buzzword-density MCP — wraps StupidAPIs (requires X-API-Key)
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
NCI CACTUS Chemical Identifier Resolver MCP.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
California DMV: vehicle and EV registrations by ZIP, field offices, forms, insurer NAIC codes
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
California Grants Portal MCP — open State of California grant funding opportunities (keyless).
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
Calendly MCP Pack — wraps the Calendly API v2 for scheduling data.
Compare Entities
"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.
| Parameter | Type | Description |
|---|---|---|
| type* | string |
Entity type: "company" or "drug".
one of: company, drug
|
| values* | array | For company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]). |
* required
Author's annotations: readOnlyHint=True, openWorldHint=True, idempotentHint=True, destructiveHint=False. These are claims by whoever wrote the server, not something we verified.
What this page is
Every field above is reproduced as the server published it at the time shown. The description and the annotations are claims by the server's author. Toolpin does not call tools, so we cannot tell you whether a tool does what it says.
What we can tell you is whether the claim changed. The hash covers the fields the MCP specification defines, so a vendor build stamp does not move it but a rewritten description does. See how we monitor, or this server's change history.